UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 10 von 149
Datensatz exportieren als...
BibTeX
Calpain-mediated truncation of GSK-3 in post-mortem brain samples
Journal of neuroscience research, 2009-04, Vol.87 (5), p.1156-1161
Goñi-Oliver, Paloma
Avila, Jesús
Hernández, Félix
2009
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Goñi-Oliver, Paloma
Avila, Jesús
Hernández, Félix
Titel
Calpain-mediated truncation of GSK-3 in post-mortem brain samples
Ist Teil von
Journal of neuroscience research, 2009-04, Vol.87 (5), p.1156-1161
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2009
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
GSK‐3 activity can be regulated by phosphorylation and through interaction with GSK‐3‐binding proteins. In addition, we have recently demonstrated that calpain activation produces a truncation of GSK‐3 that removes the N‐terminal inhibitory domain (Goñi‐Oliver et al. [2007] J. Biol. Chem. 282:22406). Given that calpain is involved in post‐mortem proteolysis in brain samples, the objective of this investigation was to test whether GSK‐3 is truncated in post‐mortem samples. To achieve this objective, we first investigated the degradation of GSK‐3 during different post‐mortem intervals in mouse brains and found that the conversion of GSK‐3 to proteolytic fragments of 40 and 30 kDa takes place in a way similar that of to p35‐CDK‐5 subunit and spectrin, two well‐known calpain substrates. In addition, we demonstrated that this truncation is mediated by calpain, insofar as pretreatment with MDL 28170, a permeable blood–brain barrier calpain inhibitor, partially inhibited that degradation. When human brain extracts were exposed to calcium, GSK‐3 was truncated, generating two fragments of approximately 40 and 30 kDa, a proteolytic process that was inhibited by calpeptin, a specific calpain inhibitor. Thus, this is the first report of calcium‐dependent truncation of human GSK‐3. These data demonstrate that control samples with similar post‐mortem delay are essential to interpret correctly the changes observed in GSK‐3 levels in human post‐mortem brain, especially when studying human neurodegenerative diseases. © 2008 Wiley‐Liss, Inc.
Sprache
Englisch
Identifikatoren
ISSN: 0360-4012
eISSN: 1097-4547
DOI: 10.1002/jnr.21932
Titel-ID: cdi_proquest_miscellaneous_66979079
Format
–
Schlagworte
Aged
,
Analysis of Variance
,
Animals
,
Blotting, Western
,
Brain - metabolism
,
calpain
,
Calpain - antagonists & inhibitors
,
Calpain - metabolism
,
Cysteine Proteinase Inhibitors - pharmacology
,
Dipeptides - pharmacology
,
Electrophoresis, Polyacrylamide Gel
,
Glycogen Synthase Kinase 3 - metabolism
,
GSK-3
,
Humans
,
Male
,
Mice
,
Mice, Inbred C57BL
,
Middle Aged
,
post-mortem
,
Postmortem Changes
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX